Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Expanded Indications in the Pediatric BONEBRIDGE Population

NCT: NCT05615649 · ACTIVE_NOT_RECRUITING

NCT IDNCT05615649
StatusACTIVE_NOT_RECRUITING
Start Date2023-10-03
Completion2026-10
SponsorMed-El Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.

Frequently Asked Questions

What is Expanded Indications in the Pediatric BONEBRIDGE Population?

Expanded Indications in the Pediatric BONEBRIDGE Population is a clinical trial registered under NCT05615649. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05615649?

The current status of NCT05615649 (Expanded Indications in the Pediatric BONEBRIDGE Population) is: ACTIVE_NOT_RECRUITING.

When did Expanded Indications in the Pediatric BONEBRIDGE Population start?

Expanded Indications in the Pediatric BONEBRIDGE Population started on 2023-10-03.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.